Completed NA INTERVENTIONAL 3-arm NCT01185379

The Effects of Efalex Active 50+ on Cognitive Performance, Well-being and Cerebral Hemodynamics in Healthy Older Adults

Investigation of the Effects of Efalex Active 50+ on Cognitive Performance, Well-being and Cerebral Hemodynamics in Healthy Adults Aged 50-70 Years Reporting Subjective Memory Deficits

Sponsor: Efamol Ltd

Conditions Cerebral Blood Flow Cognitive Function Mood Well-being

Interventions DHA rich fish oil Efalex active 50+ Placebo

Updated 5 times since 2017 Last updated: Sep 25, 2012 Started: Jul 31, 2010 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cerebral Blood Flow and Cognitive Function, this trial is completed. The trial is conducted by Efamol Ltd and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Efamol Ltd
Northumbria University

Data source: Northumbria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newcastle upon Tyne, United Kingdom